These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 15026082

  • 1. The proliferative effects of 5-androstene-3 beta,17 beta-diol and 5 alpha-dihydrotestosterone on cell cycle analysis and cell proliferation in MCF7, T47D and MDAMB231 breast cancer cell lines.
    Aspinall SR, Stamp S, Davison A, Shenton BK, Lennard TW.
    J Steroid Biochem Mol Biol; 2004 Jan; 88(1):37-51. PubMed ID: 15026082
    [Abstract] [Full Text] [Related]

  • 2. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha.
    Maggiolini M, Donzé O, Jeannin E, Andò S, Picard D.
    Cancer Res; 1999 Oct 01; 59(19):4864-9. PubMed ID: 10519397
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.
    Pérez-Palacios G, Santillán R, García-Becerra R, Borja-Cacho E, Larrea F, Damián-Matsumura P, González L, Lemus AE.
    J Endocrinol; 2006 Sep 01; 190(3):805-18. PubMed ID: 17003281
    [Abstract] [Full Text] [Related]

  • 5. 17 alpha androstenediol inhibition of breast tumor cell proliferation in estrogen receptor-positive and -negative cell lines.
    Huynh PN, Carter WH, Loria RM.
    Cancer Detect Prev; 2000 Sep 01; 24(5):435-44. PubMed ID: 11129985
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Influence of dehydroepiandrosterone and 5-en-androstene-3 beta, 17 beta-diol on the growth of MCF-7 human breast cancer cells induced by 17 beta-estradiol.
    Boccuzzi G, Brignardello E, di Monaco M, Forte C, Leonardi L, Pizzini A.
    Anticancer Res; 1992 Sep 01; 12(3):799-803. PubMed ID: 1535770
    [Abstract] [Full Text] [Related]

  • 8. Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors.
    Jansson A, Gunnarsson C, Stål O.
    Endocr Relat Cancer; 2006 Sep 01; 13(3):875-84. PubMed ID: 16954436
    [Abstract] [Full Text] [Related]

  • 9. Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines.
    Ortmann J, Prifti S, Bohlmann MK, Rehberger-Schneider S, Strowitzki T, Rabe T.
    Gynecol Endocrinol; 2002 Apr 01; 16(2):113-20. PubMed ID: 12012621
    [Abstract] [Full Text] [Related]

  • 10. The metabolism of [4-14C]5-androstene-3 beta, 17 beta-diol by normal human skin in vitro.
    Faredin I, Tóth I.
    Acta Med Acad Sci Hung; 1975 Apr 01; 32(2):139-52. PubMed ID: 1235221
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells.
    Chang CJ, Chiu JH, Tseng LM, Chang CH, Chien TM, Wu CW, Lui WY.
    Eur J Clin Invest; 2006 Aug 01; 36(8):588-96. PubMed ID: 16893382
    [Abstract] [Full Text] [Related]

  • 13. Si-Wu-Tang and its constituents promote mammary duct cell proliferation by up-regulation of HER-2 signaling.
    Chang CJ, Chiu JH, Tseng LM, Chang CH, Chien TM, Chen CC, Wu CW, Lui WY.
    Menopause; 2006 Aug 01; 13(6):967-76. PubMed ID: 17075435
    [Abstract] [Full Text] [Related]

  • 14. Partial agonist/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol.
    Chen F, Knecht K, Leu C, Rutledge SJ, Scafonas A, Gambone C, Vogel R, Zhang H, Kasparcova V, Bai C, Harada S, Schmidt A, Reszka A, Freedman L.
    J Steroid Biochem Mol Biol; 2004 Aug 01; 91(4-5):247-57. PubMed ID: 15336702
    [Abstract] [Full Text] [Related]

  • 15. [Modulation of the growth of cultured human mammary cancer cells MCF-7 by C19 steroids].
    Najid A.
    Bull Cancer; 1991 Aug 01; 78(7):611-8. PubMed ID: 1912672
    [Abstract] [Full Text] [Related]

  • 16. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM, El-Awady RA, Abdel Alim MA, Abdel Wahab AH.
    Cell Biochem Biophys; 2009 Aug 01; 55(2):95-105. PubMed ID: 19593673
    [Abstract] [Full Text] [Related]

  • 17. Effects of aminoglutethimide on delta 5-androstenediol metabolism in postmenopausal women with breast cancer.
    Bird CE, Masters V, Sterns EE, Clark AF.
    Cancer Res; 1982 Nov 01; 42(11):4797-800. PubMed ID: 6290048
    [Abstract] [Full Text] [Related]

  • 18. On the role of 17 alpha-estradiol and 17 beta-estradiol in the proliferation of MCF7 and T47D-A11 human breast tumor cells.
    Papendorp JT, Schatz RW, Soto AM, Sonnenschein C.
    J Cell Physiol; 1985 Dec 01; 125(3):591-5. PubMed ID: 4066773
    [Abstract] [Full Text] [Related]

  • 19. Partitioning of 5alpha-dihydrotestosterone and 5alpha-androstane-3alpha, 17beta-diol activated pathways for stimulating human prostate cancer LNCaP cell proliferation.
    Nunlist EH, Dozmorov I, Tang Y, Cowan R, Centola M, Lin HK.
    J Steroid Biochem Mol Biol; 2004 Jul 01; 91(3):157-70. PubMed ID: 15276623
    [Abstract] [Full Text] [Related]

  • 20. Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer.
    Boulay A, Rudloff J, Ye J, Zumstein-Mecker S, O'Reilly T, Evans DB, Chen S, Lane HA.
    Clin Cancer Res; 2005 Jul 15; 11(14):5319-28. PubMed ID: 16033851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.